Abstract. Thermally induced rearrangements of 4-hydroxycyclobutenones are known to provide clean and reliable access to an array of useful carbocyclic and fused heterocyclic ring systems. Rarely, such reactions have been diverted to an alternative pathway leading to furanone formation. Herein we show that these switches in the course of the rearrangement occur when a substrate bears a bulky substituent and are due to adverse steric buttressing as the transition state for electrocyclisation is approached. We also show how the reaction provides new opportunities for furanone synthesis and how bulky proton and halogen surrogates can be used to divert classical rearrangement pathways toward furanone formation. Additionally, we show that classical rearrangement pathways can be promoted by the simple expedient of alcohol protection.
possible from their thermochemical rearrangement (Scheme 1). For the most part outcomes are dictated by the nature of the C4 residue and are highly predictable, as evidenced by their use as key steps in many target syntheses. [3] [4] [5] [6] As interest in these reactions has grown, so has the number of reported anomalies. Most relate to thermochemical rearrangements that have been diverted from their usual course toward furanone formation. 2, [7] [8] [9] [10] Though largely viewed as oddities, such outcomes have generally been attributed to an opening of the cyclobutenone to a vinylketene akin to (E)-4 due to steric or electronic factors, 2, 8 or hydrogen bonding. 9 We recently encountered such an anomaly when effecting the thermolysis of (dimethylamino)cyclobutenone 9h. In stark contrast to all reported examples of phenylcyclobutenone rearrangements, e.g. 9a-g → 10a-g (Scheme 2), it gave furanone 11h rather than the anticipated quinone 10h. 6, [10] [11] [12] [13] [14] [15] [16] [17] Moreover, its lower homolog 9i and phenylmethylamino analogue 9j each followed the expected course, giving quinones 10i and 10j respectively. Scheme 2. An anomalous rearrangement of arylcyclobutenone 9h to furanone 11h rather than the anticipated benzoquinone 10h.
As uncertainty reduces confidence in a reaction and lessens its appeal in synthesis, we decided to determine the origin of this dichotomous behaviour.
Computational analyses of cyclobutenone ring openings involving substrates akin to 9 have always shown them to be torquoselective processes. Indeed, all favour outward rotation of the hydroxyl group to vinylketene 17 over its inward rotation to geometric isomer 16 (typically by
Template for SYNTHESIS © Thieme Stuttgart · New York 2017-06-30 page 2 of 14 ~6 kcalmol -1 , Figure 1 ). 6, 24 Preliminary DFT calculations (Supporting Information) on systems that exhibited anomalous behaviour confirmed this preference suggesting that the origin of the dichotomy lay further along the reaction co-ordinate. A cursory analysis of known anomalies showed that all involved 2,3-disubstituted cyclobutenones. Additionally, comparison of these with analogues giving expected outcomes indicated that furanones were given when the cyclobutenone carried a bulky carbon or 3°-amine substituents. This observation led us to wonder whether steric buttressing might be involved. 25 In particular, for electrocyclic ring closure of vinylketene intermediate 17 to be realised (Figure 1 ), substituents X and Y must rotate toward one another in order to attain the transition state for cyclisation, 15. When one or both of these substituents are bulky, the steric interaction between them will be severe, raising the activation energy significantly. Indeed, were this to be raised above that for opening of cyclobutenone 9 to the isomeric ketene 16, the course of rearrangement would switch to favour furanone 11. 2, 6 Critically, while steric interactions between substituents X and Y would be expected to raise the activation energy for transition state 12 by a similar amount, this has no impact on the course of the reaction as it stays below the activation energy for transition state 15.
For this hypothesis to provide a unified explanation for the anomalous outcomes in thermal cyclobutenone rearrangements we first needed to demonstrate that the influence of bulky carbon and 3°-amine substituents were comparable. To that end, we prepared t-butylcyclobutenones 9l, 9n and 9o and compared their thermolysis with the outcomes given by the corresponding methylcyclobutenones 9k, 9m and 9e (Scheme 3). 14, 15 As anticipated, the former all gave the corresponding Scheme 3. Dichotomous reactivity in the thermal rearrangements of tert-butyl-4-arylcyclobutenones. † 9o contained 25% of a regioisomer.
furanone 11 while the latter gave the classic Moore rearrangement product 10, following air oxidation.
Next, we used DFT calculations to determine the structures of vinylketene intermediates 17h-j and 17o in order to ascertain why the dimethylamino residue in 9h mirrored the tert-butyl residue in 9o rather than the methylamino and methylphenylamino residues in 9i and 9j. Calculations revealed that in all cases the amine residues would establish a hydrogen bond with the proximal hydroxyl group (Figure 2 ). This was weakest for the methylphenylamino analogue 17j due to lone pair conjugation and its near planar geometry. By contrast, the methylamino and dimethylamino residues showed significant pyramidalization at nitrogen such that it approached sp 3 hybridisation in both 17h and 17i. Indeed, it seems that pyramidalization of the dimethylamino residue in 17h ensures that it imparts a steric influence similar to that of the tert-butyl residue in 17o to impede rotation of the ketene moiety toward the phenyl residue. By contrast, the amine residues in 17i and 17j offer little resistance to ketene rotation so can readily adopt the transition state 15 for electrocyclic ring closure. The buttressing effect was next examined with 3-pyridinocyclobutenone 19c. As expected, while the reported thermal rearrangements of 19a and 19b each favoured electrocyclisation to the corresponding quinoline 20 and/or isoquinoline 21 (Scheme 4), the tert-butyl residue at C2 in cyclobutenone 19c ensured that it gave furanone 22c as the sole identified product. 2, 14, 15 Scheme 4. Dichotomous rearrangements of pyridinocyclobutenones.
Having mimicked our earlier finding (Scheme 2), we next sought to extend our survey to alkynylcyclobutenones 23 where, to the (Scheme  5) . Notably, while thermolysis of (methylamino)cyclobutenone 23f gave a complex product mixture, the related (dimethylamino)cyclobutenones 23g-j gave furanones 26g-j respectively. Similarly, (dimethylamino)cyclobutenones 23r-t gave furanones 26r-t showing that the switch in reaction course was largely independent of the nature of the alkyne residue. Another point of interest came with our examination of the photochemical rearrangement of these aminocyclobuteneones. Though precedent suggested that these would give furanones 26 in high yield, they proved to be low yielding processes giving rise to complex product mixtures. 2
Scheme 5. Dichotomous rearrangements of alkynylcyclobutenones.
Having demonstrated the wide impact of steric buttressing on cyclobutenone rearrangements, we next sought a means of switching the course of such reactions back to classical rearrangement pathways. Protection of the C4 alcohol, 8, 18, 23 provided a simple means of shutting down furanone formation as exemplified by the rearrangements of trimethylsilyl ethers 27 to quinone 28 and 29 to cyclopentenedione 30 (Scheme 6).
Scheme 6. Shutting down furanone formation by alcohol protection.
We have also been able to bias reactions toward furanone formation by employing a triisopropylsilyl substituent as a bulky proton or halide surrogate (Scheme 7). Thus, while thermolysis of arylcyclobutenone 9p for 3 h at 150 °C gave a mixture of furanone 11p and benzoquinone 10p, its triisopropylsilyl analogue 9q gave furanone 11q in 85% isolated yield following thermolysis at 150 °C for 1 h.
Importantly, protonolysis of 11q provided furanone 11p in quantitative yield while its treatment with NIS provided iodide 31. 26 The triisopropylsilyl substituent was equally effective as a steric buttress when neighboured by a dimethylamino residue, as evidenced by the conversion of arylcyclobutenone 9r to furanones 11r and 32.
Scheme 7. Using a triisopropylsilyl group as a bulky proton and halogen surrogate to bias reactions toward furanone formation.
In summary, thermally induced rearrangements of 4-hydroxycyclobutenones are likely to give furanones when the alkene bears a bulky substituent. This switch away from the usual reaction course is due to adverse buttressing of substituents when the transition state for electrocyclisation is approached. Alcohol protection provides a means of shutting down furanone formation while the inclusion of a bulky proton or halogen surrogate, such as a triisopropylsilyl group, provides a means of directing rearrangements toward furanone formation.
The experimental section has no title; please leave this line here.
Melting points were recorded on an Electrothermal IA9100 digital melting point apparatus and are uncorrected. Infrared Spectra were recorded neat as thin films or as solid compressions using a Nicolet 380 Laboratory FT-IR spectrometer or a Nicolet iS5 Laboratory FT-IR spectrometer. NMR Spectra were recorded on a Bruker AVIIIHD 400 or a Bruker AVIIIHD 500 spectrometer at 298 K using CDCl3 stored over dried K2CO3 to neutralise trace acidity unless stated otherwise. Assignments have been made on the basis of chemical shifts, coupling constants, DEPT-135, COSY, HMQC and comparison with literature values. High Resolution Mass Spectrometry was carried out using a MaXis (Bruker Daltonics, Bremen, Germany) mass spectrometer equipped with a time of flight (TOF) analyser. Samples were introduced to the mass spectrometer via a Dionex Ultimate 3000 autosampler and uHPLC pump using a gradient of 20% to 100% acetonitrile (0.1% formic acid) over five minutes. Spectra were recorded using positive/negative ion electrospray ionization as specified and were calculated to four decimal places from the molecular formula. All samples were recorded by Ms. Julie Herniman at the University of Southampton. Low Resolution Mass Spectrometry was carried out using electrospray ionisation on a directly injected WATERS quadrupole MSD using ESI+ with MeOH/acetonitrile as solvent. X-ray data were recorded by Dr Mark Light at the UK National Crystallography Service, University of Southampton using a Rigaku AFC12 FRE-HF diffractometer equipped with an Oxford Cryosystems low-temperature apparatus operating at 100 K.
Thin layer chromatography was carried out on Merck Silica Gel 60 Å F 254 0.2 mm plates, which were visualised under fluorescence UV (254 nm) followed by staining with iodine and/or aqueous 1% KMnO4, methanolic H2SO4. Column chromatography was carried out under slight positive pressure using silica gel with the stated solvent system. Reagents that were commercially available were purchased and used without further purification unless stated otherwise. THF was distilled 
3-Methyl-4-(methylamino)-cyclobutene-1,2-dione (34b).
A solution of methylamine hydrochloride (440 mg, 6.52 mmol) and triethylamine (0.9 mL, 6.5 mmol) in MeOH (10 mL) was added to a solution of 3-methoxy-4-methylcyclobutene- 
3-(Dibenzylamino)-4-methylcyclobut-3-ene-1,2-dione (34e) 28
To a cooled (0 °C) solution of 3-methoxy-4-methylcyclobutene-1,2-dione (126 mg, 1.00 mmol) in MeOH (50 mL) was added dibenzylamine (0.10 mL, 1.0 mmol). After 2 h the solution was warmed to RT and after a further 2 h was concentrated under reduced pressure. Purification by column chromatography (EtOAc) afforded the title compound 42 (160 mg, 0.55 mmol, 55%) as a pale yellow oil. 
3-(Dimethylamino)-4-hydroxy-2-methyl-4-phenylcyclobut-2-en-1-one (9h)
To a solution of 3-(dimethylamino)-4-methylcyclobut-3-ene-1,2-dione 34a (140 mg, 1.01 mmol) in THF (50 mL) at -78 °C was added phenyllithium (1.9 M in Bu2O, 0.69 mL, 1.31 mmol) dropwise. After 1 h, sat. NH4Cl (20 mL) was added and the reaction mixture was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4 and concentrated under reduced pressure. Purification by column 
4-Hydroxy-2-methyl-3-methylamino-4-phenylcyclobut-2-en-1-one (9i)
To a solution of 3-methylamino-4-methylcyclobutene-1,2-dione 34b (434 mg, 3.58 mmol) in THF (50 mL) at -78 °C was added phenyllithium (1.9 M in Bu2O, 4.6 mL, 8.7 mmol) dropwise. After 2 h, sat. NH4Cl (20 mL) was added and the reaction mixture was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4 and concentrated under reduced pressure. Purification by recrystallization (Et2O) afforded the title product 9i (635 mg, 3.13 mmol, 87%) as an off-white solid.
MP: 187 °C dec. 
4-Hydroxy-2-methyl-3-(methyl(phenyl)amino)-4-phenylcyclobut-2-en-1-one (9j)
To a solution of 3-(methyl(phenyl)amino)-4-methylcyclobut-3-ene-1,2-dione 34c (303 mg, 1.51 mmol) in THF (50 mL) at -78 °C was added phenyllithium (1.9 M in Bu2O, 1.1 mL, 2.1 mmol) dropwise. After 2 h, sat. NH4Cl (20 mL) was added and the reaction mixture was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4 and concentrated under reduced pressure.
Purification by column chromatography (Et2O) afforded the title compound 9j (309 mg, 1.11 mmol, 74%) as a white solid. To a solution of dimethyl squarate 35 (350 mg, 2.46 mmol) in THF (50 mL) at -78 °C was added t BuLi (1.7 M in pentane, 1.6 mL, 2.71 mmol) dropwise. After 30 min TFAA (0.41 mL, 2.95 mmol) was added dropwise followed after a further 20 min by sat. NH4Cl (20 mL). The solution was warmed to RT then the aqueous phase was separated and extracted with DCM (2 × 50 mL). The organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (50-100% Et2O/petrol) to afford 3-(tert-butyl)-4-methoxycyclobut-3-ene-1,2-dione 36 (398 mg, 2.37 mmol, 96%) as a yellow oil. 
2-(tert-Butyl)-4-hydroxy-3-methoxy-4-phenylcyclobut-2-en-1-one (9l)
To a solution of 2-(tert-butyl)-4-methoxycyclobut-3-ene-1,2-dione 36 (340 mg, 2.02 mmol) in THF (50 mL) at -78 °C was added phenyllithium (1.9 M in Bu2O, 1.3 mL, 2.5 mmol) dropwise. After 2 h sat. NH4Cl (20 mL) was added then the reaction mixture was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4 and concentrated under reduced pressure. Purification by column chromatography (10-50% EtOAc/petrol) afforded the title product 9l (390 mg, 1.58 mmol, 78%) as a yellow oil. 30 To a solution of dimethyl squarate 35 (350 mg, 2.46 mmol) in THF (50 mL) at -78 °C was added MeLi (1.6 M in hexanes, 1.9 mL, 3.0 mmol) dropwise. After 1 h t BuLi (1.7 M in pentane, 2.0 mL, 3.4 mmol) was added dropwise followed after 30 min by TFAA (0.87 mL, 6.2 mmol). After a further 20 min sat. NH4Cl (20 mL) was added and solution 
3-(tert-Butyl)-4-methylcyclobut-3-ene-1,2-dione (37)

2-(tert-Butyl)-4-hydroxy-3-(methylamino)-4-phenylcyclobut-2-en-1-one (9n)
To a solution of 3-(tert-butyl)-4-(methylamino)cyclobut-3-ene-1,2-dione 38 (300 mg, 1.79 mmol) in THF (50 mL) at -78 °C was added phenyllithium (1.9 M in Bu2O, 2.4 mL, 4.6 mmol) dropwise. After 2 h sat. NH4Cl (20 mL) was added and the reaction mixture was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL 
4-(Dimethylamino)-3-methyl-5-phenylfuran-2(5H)-one (11h)
Cyclobutenone 9h (100 mg, 0.46 mmol) in dioxane (10 mL) was heated at 180 °C in stainless steel tubing under continuous flow for a residence time of 2 h. 2-Methyl-3-(methylamino)naphthalene-1,4-dione (10i) 31 A solution of 4-hydroxy-2-methyl-3-methylamino-4-phenylcyclobut-2-en-1-one 9i (200 mg, 0.99 mmol) in tetraethylene glycol dimethyl ether (10 mL) was heated at 160 °C for 5 h under argon then cooled to RT and stirred for 1 h under air. Water (50 mL) was added and the reaction mixture was extracted with Et2O (3 × 100 mL). The combined organic layers were washed with H2O (3 × 300 mL), dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (10-30% Et2O/petrol) to afford the title product 10i (145 mg, 0.72 mmol, 73%) as a dark red solid. 
3-(tert-Butyl)-4-(methylamino)-5-phenylfuran-2(5H)-one (11n)
A solution of 2-(tert-butyl)-4-hydroxy-3-(methylamino)-4-phenylcyclobut-2-en-1-one 9n (200 mg, 0.82 mmol) in tetraethylene glycol dimethyl ether (10 mL) was heated at 180 °C under argon for 2 h then cooled to RT. Water (50 mL) was added and the reaction mixture was extracted with Et2O (3 × 100 mL). The combined organic phases were washed with H2O (3 × 300 mL), dried over 
4-(tert-Butyl)-3-methyl-5-phenylfuran-2(5H)-one (11o)
An inseparable 2 : 1 mixture of 2-(tert-butyl)-4-hydroxy-3-methyl-4-phenylcyclobut-2-en-1-one 9o and 3-(tert-butyl)-4-hydroxy-2-methyl-4-phenylcyclobut-2-en-1-one 9s was dissolved in dioxane (10 mL) and heated at 170 °C in stainless steel tubing under continuous flow for a residence time of 1 h. The resulting solution was concentrated under reduced pressure and purified by column chromatography (20-80% Et2O/petrol) to afford 11o (252 mg, 1.09 mmol, 67%) as a yellow oil. 
IR (film)
:
2-(tert-Butyl)-4-hydroxy-3-methoxy-4-(pyridin-3-yl)cyclobut-2-en-1-one (19c)
To a solution of 3-bromopyridine (0.3 mL, 3.1 mmol) in THF (20 mL) at -78 °C was added n BuLi (2.5 M in hexanes, 1.25 mL, 3.13 mmol) dropwise. After 15 min the solution was added via cannula to a solution of 2-(tertbutyl)-4-methoxycyclobut-3-ene-1,2-dione 36 (403 mg, 2.40 mmol) in THF (50 mL) at -78 °C. After a further 1 h sat. NH4Cl (20 mL) was added and the solution was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (20%-50% EtOAc/petrol) to afford the title compound 19c (207 mg, 0.84 mmol, 35%) as a yellow oil. 
3-(tert-Butyl)-4-methoxy-5-(pyridin-3-yl)furan-2(5H)-one (22c)
Cyclobutenone 19c 
3-(Dimethylamino)-4-hydroxy-2-methyl-4-(phenylethynyl)cyclobut-2-enone (23g)
To a solution of phenylacetylene (0.07 mL, 0.65 mmol) in THF (20 mL) at -78 °C was added n BuLi (2.4 M in hexanes, 0.27 mL, 0.65 mmol) dropwise. After 10 min the solution was added via cannula to a solution of 3-dimethylamino-4-methylcyclobutene-1,2-dione 34a (68 mg, 0.49 mmol) in THF (10 mL) at -78 °C. After a further 50 min sat. NH4Cl (20 mL) was added and the solution was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (70%-100% EtOAc/hexane) to afford the title compound 23g (83 mg, 0.34 mmol, 70%) as a white solid. 
4-(Dimethylamino)-3-methyl-5-(phenylethynyl)furan-2(5H)-one (26g)
Cyclobutenone 23g (75 mg, 0.31 mmol) in dioxane (5 mL) was heated at 150 °C in stainless steel tubing under continuous flow for a residence time of 1 h. 
3-(Diethylamino)-4-hydroxy-2-methyl-4-(phenylethynyl)cyclobut-2-en-1-one (23h)
To a solution of phenylacetylene (0.14 mL, 1.25 mmol) in THF (20 mL) at -78 °C was added n BuLi (2.4 M in hexanes, 0.53 mL, 1.27 mmol) dropwise. After 10 min the solution was added via cannula to a solution of 3-(diethylamino)-4-methylcyclobutene-1,2-dione 34d (161 mg, 0.96 mmol) in THF (40 mL) at -78 °C. After a further 2 h sat. NH4Cl (20 mL) was added and the solution was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (5%-30% acetone/DCM) to afford the title compound 23h (208 mg, 0.78 mmol, 81%) as a yellow oil. 
3-(Dibenzylamino)-4-hydroxy-2-methyl-4-(phenylethynyl)-cyclobut-2-enone (23i)
To a solution of phenylacetylene (0.10 mL, 0.90 mmol) in THF (20 mL) at -78 °C was added n BuLi (2.4 M in hexanes, 0.38 mL, 0.90 mmol) dropwise. After 10 min the solution was added via cannula to a solution of 3-(dibenzylamino)-4-methylcyclobutene-1,2-dione 34e 10 
4-(Dibenzylamino)-3-methyl-5-(phenylethynyl)furan-2(5H)-one (26i)
Cyclobutenone 23i (180 mg, 0.46 mmol) in dioxane (10 mL 
3-(Dimethylamino)-4-hydroxy-2-phenyl-4-(phenylethynyl)-cyclobut-2-enone (23j).
To a solution of phenylacetylene (0.07 mL, 0.65 mmol) in THF (20 mL) at -78 °C was added n BuLi (2.4 M in hexanes, 0.27 mL, 0.65 mmol) dropwise. After 10 min the solution was added via cannula to a solution of 3-(dimethylamino)-4-phenylcyclobutene-1,2-dione (100 mg, 0.50 mmol) in THF (20 mL) at -78 °C. After a further 90 min sat. NH4Cl (20 mL) was added and the solution was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL). The organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (10-50% acetone/cyclohexane) to afford the title compound 23j (131 mg, 0.42 mmol, 83%) as a yellow solid.
MP: 120 °C dec. 
4-(Dimethylamino)-3-methyl-5-((trimethylsilyl)ethynyl)furan-2(5H)-one (26r)
Cyclobutenone 23r (120 mg, 0.50 mmol) in dioxane (10 mL) was heated at 150 °C in stainless steel tubing under continuous flow for a residence time of 1 h. The resulting solution was concentrated under reduced pressure and purified by column chromatography (50-80% Et2O/cyclohexane) to afford the title compound 26r (80 mg, 0.34 mmol, 67%) as a yellow oil. 
3-(Dimethylamino)-4-hydroxy-2-methyl-4-(pent-1-yn-1-yl)cyclobut-2-enone (23s)
To a solution of pent-1-yne (0.17 mL, 1.74 mmol) in THF (20 mL) at -78 °C was added n BuLi (2.3 M in hexanes, 0.75 mL, 1.73 mmol) dropwise. After 10 min the solution was added via cannula to a solution of 3-dimethylamino-4-methylcyclobutene-1,2-dione 34a (186 mg, 1.39 mmol) in THF (20 mL) at -78 °C. After a further 4 h sat. NH4Cl (20 mL) was added and the solution was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (0-20% acetone/DCM) to afford the title compound 23s (210 mg, 1.01 mmol, 75%) as a yellow oil. To a solution of 2-methylbut-1-en-3-yne (0.17 mL, 1.74 mmol) in THF (20 mL) at -78 °C was added n BuLi (2.4 M in hexanes, 0.75 mL, 1.74 mmol) dropwise. After 10 min the solution was added via cannula to a solution of 3-dimethylamino-4-methylcyclobutene-1,2-dione 34a (186 mg, 1.39 mmol) in THF (20 mL) at -78-°C. After a further 2 h sat. NH4Cl (20 mL) was added and the solution was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (0-30% acetone/DCM) to afford the title compound 23t (221 mg, 1.07 mmol, 80%) as a yellow oil. 
3-(Dimethylamino)-2-methyl-4-(pent-1-yn-1-yl)-4-((trimethylsilyl) oxy)cyclobut-2-enone (27)
To a solution of aminocyclobutenone 23s (330 mg, 1.59 mmol) and triethylamine (0.23 mL, 1.8 mmol) in THF (50 mL) at 0 °C was added TMSCl (0.23 mL, 1.8 mmol) dropwise. After 2 h sat. NH4Cl (10 mL) was added and the solution was warmed to RT. The aqueous phase was separated and extracted with DCM (2 × 50 mL) then the organic phases were combined, dried over MgSO4, concentrated under reduced pressure and purified by column chromatography (0-30% DCM/petrol) to afford the title compound 27 (310 mg, 1.11 mmol, 70%) as a yellow oil. 
3-(Dimethylamino)-2-methyl-4-(phenylethynyl)-4-((trimethylsilyl) oxy)cyclobut-2-enone (29)
To a solution of aminocyclobutenone 24c (180 mg, 0.75 mmol) and triethylamine (0.10 mL, 0.9 mmol) in THF (50 mL) at 0 °C was added TMSCl (0.11 mL, 0.9 mmol) dropwise. After 2 h sat. NH4Cl (10 mL) was added and the solution was warmed to RT. To a solution of 3-ethoxy-4-(triisopropylsilyl)cyclobut-3-ene-1,2-dione 39 32 (2.63 g, 9.30 mmol) in EtOH (120 mL) at 0 °C was added piperidine (1.3 mL, 13.3 mmol) dropwise over 5 min. The reaction mixture was allowed to warm to RT and after 50 min was concentrated under reduced pressure and purified by column chromatography (10-15% EtOAc/petrol) to afford the title compound 40 (2.75 g, 9.72 mmol, 96%) as a yellow solid. 
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5-Phenyl-4-(piperidin-1-yl)-3-(triisopropylsilyl)furan-2(5H)-one (11q)
Aminocyclobutenone 9q (100 mg, 0.25 mmol) in dioxane (10 mL) was heated at 150 °C in stainless steel tubing under continuous flow for a residence time of 1 h. X-ray: see insert.
5-Phenyl-4-(piperidin-1-yl)furan-2(5H)-one (11p)
To silylfuranone 11q (53 mg, 0.13 mmol) in THF (5 mL) was added 2M HCl (2 mL). After 3 h, sat. NaHCO3 (10 mL) was added then the aqueous phase was separated and extracted with CHCl3 (3 × 20 mL). The organic phases were combined, dried over MgSO4, filtered and concentrated under reduced pressure. Purification by column chromatography (10-40% EtOAc/petrol) afforded the title compound 11p (32 mg, 0.13 mmol, 100%) as a white solid. 
3-Iodo-5-phenyl-4-(piperidin-1-yl)furan-2(5H)-one (31)
A solution of silylfuranone 11q (60 mg, 0.15 mmol) and Niodosuccinimide (50.7 mg, 0.23 mmol) in hexafluoroisopropanol (5 mL) was stirred at -20 °C for 2 h then sat. NaHCO3 (5 mL) and sat. Na2S2O3 (2 mL) were added. The aqueous phase was separated and extracted with CHCl3 (3 × 15 mL). The organic phases were combined, dried over MgSO4, filtered and concentrated under reduced pressure. Purification by column chromatography (0-20% EtOAc/petrol) afforded the title compound 31 (41 mg, 0.11 mmol, 73%) as an off white solid. 
